1. Home
  2. AGMH vs VTAK Comparison

AGMH vs VTAK Comparison

Compare AGMH & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AGM Group Holdings Inc.

AGMH

AGM Group Holdings Inc.

HOLD

Current Price

$0.91

Market Cap

2.1M

Sector

Technology

ML Signal

HOLD

Logo Catheter Precision Inc.

VTAK

Catheter Precision Inc.

HOLD

Current Price

$1.13

Market Cap

2.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGMH
VTAK
Founded
2015
2002
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1M
2.2M
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
AGMH
VTAK
Price
$0.91
$1.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
117.2K
194.6K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
89.53
EPS
N/A
N/A
Revenue
N/A
$442,000.00
Revenue This Year
N/A
$1,170.33
Revenue Next Year
N/A
N/A
P/E Ratio
$0.07
N/A
Revenue Growth
N/A
3057.14
52 Week Low
$0.03
$0.15
52 Week High
$18.10
$4.31

Technical Indicators

Market Signals
Indicator
AGMH
VTAK
Relative Strength Index (RSI) 36.59 45.74
Support Level $0.83 $0.15
Resistance Level $1.36 $2.08
Average True Range (ATR) 0.11 0.12
MACD 0.02 0.04
Stochastic Oscillator 13.68 65.12

Price Performance

Historical Comparison
AGMH
VTAK

About AGMH AGM Group Holdings Inc.

AGM Group Holdings Inc is an integrated technology company. The company focuses on blockchain-oriented ASIC chip design, high-end crypto miner production, and fintech technology software services. The company generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

Share on Social Networks: